Neuroaide Company Profile

Background

Neuroaide is a technology company dedicated to revolutionizing the neuropsychological and psychoeducational evaluation process. By leveraging advanced artificial intelligence (AI), Neuroaide aims to streamline report writing for evaluators, enabling them to produce high-quality, personalized reports more efficiently. The company's mission is to alleviate the time-intensive nature of report generation, allowing professionals to focus more on patient care.

Key Strategic Focus

Neuroaide's strategic focus centers on integrating AI into the neuropsychological evaluation workflow. The platform is designed to learn from evaluators' past reports, adapting to individual writing styles, structures, and conventions. This personalization ensures that each generated report accurately reflects the evaluator's voice and the unique needs of each client. By automating the synthesis of qualitative observations and test results, Neuroaide significantly reduces the time required to produce comprehensive reports.

Financials and Funding

As of July 2025, specific details regarding Neuroaide's funding history, total funds raised, and notable investors have not been publicly disclosed. The company continues to focus on enhancing its platform and expanding its user base within the neuropsychological evaluation community.

Pipeline Development

Neuroaide's primary product is its AI-driven report generation platform tailored for neuropsychological and psychoeducational evaluators. The platform supports inputs from over 200 widely used tests, transforming unformatted notes and test scores into well-structured report sections. Users can customize the report structure by selecting the sections to include and their order. A typical Neuroaide-generated report may include sections such as:

Tests Administered

Reason for Referral

Background

Behavioral Observations

Intellectual Functioning

Attention & Executive Functioning

Memory

Visual-Spatial & Motor Processes

Reading

Written Language

Mathematics

Social-Emotional Functioning

Summary of Test Results

Recommendations

This comprehensive approach ensures that each report is thorough and tailored to the individual client.

Technological Platform and Innovation

Neuroaide's platform stands out due to its proprietary AI technology that learns from users' previous reports to match their writing style, structure, and conventions. Key technological features include:

Proprietary AI Algorithms: The system adapts to individual evaluators, ensuring that generated reports reflect the unique voice and style of each professional.

Comprehensive Data Integration: The platform synthesizes unformatted notes, intake forms, and test results into thorough, accurate, and well-organized report sections.

Customization and Flexibility: Evaluators can customize the report structure, selecting which sections to include and their order, ensuring that each report meets specific requirements.

HIPAA Compliance: Neuroaide complies with HIPAA's Privacy Rule by applying the “safe harbor” de-identification standard, ensuring that any data sent to the platform is de-identified and no longer qualifies as protected health information (PHI).

Leadership Team

Neuroaide's leadership comprises experienced professionals with backgrounds in technology and education:

Cameron Backes, Co-Founder and CEO: Before co-founding Neuroaide, Cameron served as co-founder and CEO of Stronger Brains, a digital platform focused on improving children’s neurocognitive processes. He holds both Bachelor's and Master’s degrees in Symbolic Systems from Stanford University.

David Joo, Co-Founder: David was a co-founder and co-CEO of Knowre, an education technology company specializing in personalized learning experiences for students. He holds a bachelor's degree in Biology from Carleton College.

Dr. David Porrino, Advisor: A clinical neuropsychologist and licensed psychologist, Dr. Porrino is the director of diagnostic testing services at Sasco River Center. He has extensive experience in neuropsychological assessments across various age groups.

Caryl Frankenberger, Advisor: Executive Director of Frankenberger Associates Learning Solutions Center, Caryl has over 35 years of experience in personalized education services, specializing in customized learning programs for students with complex learning profiles.

Leadership Changes

As of July 2025, there have been no publicly announced significant changes or appointments within Neuroaide's leadership team.

Competitor Profile

Market Insights and Dynamics

The neurorehabilitation devices market is experiencing significant growth, driven by the increasing incidence of neurological conditions, an aging population, and technological advancements. The global market is projected to reach $2.1 billion by 2026, growing at a compound annual growth rate (CAGR) of 14.8%. This expansion is fueled by the development of innovative devices and improved access to healthcare services.

Competitor Analysis

Neuroaide operates in a niche segment of the neurorehabilitation market, focusing on AI-driven report generation for neuropsychological evaluations. While direct competitors in this specific area are limited, several companies offer complementary or overlapping services:

Bioness Inc.: Specializes in neuromodulation and rehabilitation medical devices, offering solutions for functional electrical stimulation and robotic therapy.

Hocoma AG: Provides robotic and sensor-based devices for functional movement therapy, including solutions for gait and arm rehabilitation.

Ekso Bionics: Develops exoskeleton solutions to enhance strength, endurance, and mobility in individuals with neurological conditions.

These companies primarily focus on physical rehabilitation devices, whereas Neuroaide's emphasis is on streamlining the cognitive and administrative aspects of neuropsychological evaluations through AI.

Strategic Collaborations and Partnerships

As of July 2025, specific details regarding Neuroaide's strategic collaborations or partnerships have not been publicly disclosed. The company continues to focus on enhancing its platform and expanding its user base within the neuropsychological evaluation community.

Operational Insights

Neuroaide's competitive advantage lies in its ability to integrate AI seamlessly into the neuropsychological evaluation process. By automating and personalizing report generation, the platform addresses a critical pain point for evaluators: the time-consuming nature of report writing. This efficiency not only improves productivity but also enhances the quality of patient care by allowing professionals to dedicate more time to direct client interactions.

Strategic Opportunities and Future Directions

Looking ahead, Neuroaide has several strategic opportunities:

Expansion of AI Capabilities: Continuing to refine and expand the platform's AI algorithms to support a broader range of evaluation types and conditions.

Integration with Electronic Health Records (EHR): Developing integrations with EHR systems to streamline data input and output processes further.

Market Expansion: Exploring opportunities to expand into international markets and other areas of psychological and educational assessments.

Strategic Partnerships: Forming alliances with educational institutions, healthcare organizations, and professional associations to enhance platform adoption and credibility.

By leveraging its current strengths and focusing on these strategic areas, Neuroaide is well-positioned to continue its growth and impact in the field of neuropsychological evaluations.